RESUMEN
Nanostructuring technology has been proven to create unique biological properties in various biomaterials. Here we present a discovered phenomenon of titanium nano-nodular self-assembly that occurs during physical vapor depositions of titanium (Ti) onto specifically conditioned micro-textured titanium surfaces, and test a hypothesis that the Ti nanostructure has the potential to enhance bone-titanium integration. The nanostructure creation effectively provided geometrical undercut and increased the surface area by up to 40% compared with the acid-etched surface with microtopography. Depending on the size control, the nano-nodules can be added without smearing the existing micro-texture, creating a nano-micro-hybrid architecture. Titanium implants with 560-nm nano-nodules produced 3.1 times greater strength of osseointegration than those with an acid-etched surface in a rat femur model. The discovered titanium nano-nodular self-structuring has been proven feasible on biocompatible materials other than titanium, offering new avenues for the development of implant surfaces and other implantable materials for better bone-generative and -regenerative potential.
Asunto(s)
Implantes Dentales , Nanoestructuras/ultraestructura , Oseointegración/fisiología , Titanio , Animales , Materiales Biocompatibles/síntesis química , Materiales Biocompatibles/química , Cristalización , Nanopartículas del Metal/química , Nanopartículas del Metal/ultraestructura , Nanoestructuras/química , Ratas , Propiedades de Superficie , VolatilizaciónRESUMEN
Despite its proven cytotoxicity, poly-methyl methacrylate (PMMA) resin is one of the most frequently and extensively used materials in dental practice. This study hypothesized that an anti-oxidant amino acid, N-acetyl cysteine (NAC), has the potential to detoxify this material. Ten percent of the rat dental pulp cells were viable when cultured on the PMMA resin for 24 hours, while over 70% of the cells were viable on the NAC-added resin. Nearly all suppressed alkaline phosphatase activity, matrix mineralizing capability, and odontoblastic gene expression, such as dentin sialoprotein, on the untreated control resin was recovered by NAC in a concentration-dependent manner. A Ca/P ratio of 1.65 was found in the extracellular matrix of cultures on NAC-added resin, while that in the untreated resin culture was 0.70. The addition of NAC to PMMA resin significantly ameliorated its cytotoxicity to the dental pulp cells and restored their odontoblast-like cell phenotype to a biologically significant degree.
Asunto(s)
Acetilcisteína/farmacología , Antioxidantes/farmacología , Pulpa Dental/efectos de los fármacos , Depuradores de Radicales Libres/farmacología , Polimetil Metacrilato/toxicidad , Acetilcisteína/administración & dosificación , Fosfatasa Alcalina/antagonistas & inhibidores , Fosfatasa Alcalina/efectos de los fármacos , Animales , Antioxidantes/administración & dosificación , Apoptosis/efectos de los fármacos , Biotransformación , Calcificación Fisiológica/efectos de los fármacos , Calcio/análisis , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Colágeno Tipo I/antagonistas & inhibidores , Colágeno Tipo I/efectos de los fármacos , Pulpa Dental/citología , Relación Dosis-Respuesta a Droga , Matriz Extracelular/química , Matriz Extracelular/efectos de los fármacos , Proteínas de la Matriz Extracelular , Depuradores de Radicales Libres/administración & dosificación , Masculino , Odontoblastos/efectos de los fármacos , Fosfoproteínas/antagonistas & inhibidores , Fosfoproteínas/efectos de los fármacos , Fósforo/análisis , Precursores de Proteínas/antagonistas & inhibidores , Precursores de Proteínas/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , SialoglicoproteínasRESUMEN
Mechanisms underlying the beneficial anchorage of roughened titanium implants have not been identified. We hypothesized that the implant surface roughness alters intrinsic biomechanical properties of bone integrated to titanium. Nano-indentation performed on two- and four-week post-implantation bone specimens of rats revealed that bone integrated to acid-etched titanium was approximately 3 times harder than that integrated to the machined titanium, both at the osseointegration interface and at the inner area of the peri-implant bone. The hardness of the acid-etched surface-associated bone was equivalent to that of untreated cortical bone at week 4, while the bone hardness around the machined surface was equivalent to that of the untreated trabecular bone. The elastic modulus of the integrated bone was 1.5 to 2.5 times greater around the acid-etched surface than around the machined surface. Analysis of the data suggests that the implant surface roughness affects the biomechanical quality of osseo-integrated bone, and that the bone integrated to the acid-etched surface is harder and stiffer than the bone integrated to the machined surface.
Asunto(s)
Huesos/ultraestructura , Implantes Dentales , Materiales Dentales/química , Oseointegración/fisiología , Titanio/química , Grabado Ácido Dental , Animales , Fenómenos Biomecánicos , Huesos/fisiología , Elasticidad , Microanálisis por Sonda Electrónica , Fémur/fisiología , Fémur/ultraestructura , Dureza , Procesamiento de Imagen Asistido por Computador , Imagenología Tridimensional , Masculino , Microscopía Electrónica de Rastreo , Nanotecnología , Adhesión en Plástico , Ratas , Ratas Sprague-Dawley , Propiedades de Superficie , Tomografía Computarizada por Rayos XRESUMEN
The application of implant therapy is still limited, because of various risk factors and the long healing time required for bone-titanium integration. This study explores the potential for osseointegration engineering with dental pulp cells (DPCs) by testing a hypothesis that DPCs generate mineralized tissue on titanium. DPCs extracted from rat incisors positive for CD44, alkaline phosphatase activity, and mineralizing capability were cultured on polystyrene and on machined and dual-acid-etched (DAE) titanium. Tissue cultured on titanium with a Ca/P ratio of 1.4 exhibited plate-like morphology, while that on the polystyrene exhibited fibrous and punctate structures. Tissues cultured on titanium were harder than those on polystyrene, 1.5 times on the machined and 3 times on the DAE. Collagen I, osteopontin, and osteocalcin genes were up-regulated on titanium, especially the DAE surface. In conclusion, DPCs showing some characteristics of the previously identified dental pulp stem cells can generate mineralized tissue on titanium via the osteoblastic phenotype, which can be enhanced by titanium surface roughness.
Asunto(s)
Calcificación Fisiológica/fisiología , Pulpa Dental/citología , Titanio , Grabado Ácido Dental , Animales , Fenómenos Biomecánicos , Calcio/análisis , Colágeno Tipo I/análisis , Medios de Cultivo , Pulpa Dental/fisiología , Dureza , Masculino , Biología Molecular , Osteocalcina/análisis , Osteopontina , Fosfoproteínas/análisis , Fósforo/análisis , Poliestirenos/química , Ratas , Ratas Sprague-Dawley , Sialoglicoproteínas/análisis , Propiedades de Superficie , Técnicas de Cultivo de Tejidos , Titanio/químicaRESUMEN
1. The relationship between plasma levels of a new H2-receptor antagonist, Z-300, and an active sulphoxide metabolite, and inhibitory effects on gastric acid secretion after intravenous or oral administration to dog have been examined. After both routes of administration, Z-300 in plasma eliminated with two phases, and the terminal half-lives were approximately 2 h. The level of sulphoxide in plasma reached a maximum at 0.6-0.7 h after administration, then subsequently eliminated with a half-life of approximately 6 h. 2. The maximal pharmacological effect of inhibition of gastric acid secretion (90-91%) was observed at 2 h (i.v.) and 6 h (p.o.), and the action persisted until 7 h after administration. 3. Since there was no correlation between plasma levels of Z-300 and pharmacological effects, the pharmacological effects were calculated by pharmacodynamic model including the effect compartment. The inhibition of acid output could be calculated by the amounts of Z-300 and sulphoxide corrected by pharmacological efficacy in the effect compartment. 4. These findings suggest that Z-300 contributes to the rapid appearance of the pharmacological effects in dog, whereas the sulphoxide, which eliminates slowly in plasma, contributes to duration.
Asunto(s)
Acetamidas/farmacología , Antagonistas de los Receptores H2 de la Histamina/farmacología , Piperidinas/farmacología , Acetamidas/farmacocinética , Animales , Perros , Ácido Gástrico/metabolismo , Antagonistas de los Receptores H2 de la Histamina/farmacocinética , Masculino , Estructura Molecular , Piperidinas/farmacocinética , Estómago/efectos de los fármacos , Sulfóxidos/sangre , Factores de TiempoRESUMEN
Using porcelain and resin-mixed composites as experimental materials, cubic polymerized composites were prepared by the accumulation of thin slices cured by laser scanning. The composites were then fired, and bulk ceramic bodies were made. The optimal firing conditions of polymerized composites and firing shrinkage were investigated. The results showed that cubic ceramic bodies in a form homologous to that before firing could be reproduced. The volume shrinkage of fired ceramic bodies consisting of 1 g of ceramic powders and 0.3 g of epoxy resin was about 30% under all firing conditions, and there were no significant differences between specimens. It was suggested that with further research and development, three-dimensional forms for clinical use in dentistry could be manufactured by the proposed method.
Asunto(s)
Porcelana Dental/química , Porcelana Dental/síntesis química , Resinas Epoxi/química , Rayos Láser , Tecnología Odontológica/instrumentación , Ensayo de Materiales , Polímeros/químicaRESUMEN
We studied the anti-acetylcholinesterase (AChE) activity of a new H2-antagonist, nizatidine, in in vitro experiments and its gastroprokinetic action in the dog and rat in comparison with other H2-antagonists, neostigmine and cisapride. The IC50 of nizatidine for AChE was 6.7 x 10(-6) M, and this activity was reversible. The relative anti-AChE potency was in the following order: neostigmine > nizatidine > cimetidine >> famotidine. The inhibition of AChE by nizatidine was noncompetitive, with a Ki value of 7.4 x 10(-6) M. Gastrointestinal (GI) motility was examined during the interdigestive state in dogs with chronically implanted force transducers. Nizatidine (0.3-3 mg/kg, i.v.) significantly increased the motor index in a dose-dependent manner. It was of interest that the contractile response of the GI tract to nizatidine was similar to the interdigestive migrating contractions-like activity. At the doses used in this study, neither cimetidine nor famotidine had a significant effect on the motor index. Neostigmine at a higher dose of 0.06 mg/kg and cisapride at 0.3 mg/kg were found to stimulate GI contractions. Gastric emptying was determined in rats given phenol red as a liquid test meal. Nizatidine (3 mg/kg, i.p., or above) significantly increased gastric emptying, whereas the other H2-antagonists had no such effect. The ED50 and ED90 values of nizatidine for inhibition of gastric acid secretion were 0.18 and 3.22 mg/kg in dogs, and 2.94 and 19.6 mg/kg in rats, respectively. These findings suggest that nizatidine stimulates GI contractions and accelerates gastric emptying at gastric antisecretory doses.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Motilidad Gastrointestinal/efectos de los fármacos , Nizatidina/farmacología , Animales , Inhibidores de la Colinesterasa/farmacología , Cimetidina/farmacología , Sistema Digestivo/efectos de los fármacos , Fenómenos Fisiológicos del Sistema Digestivo , Perros , Relación Dosis-Respuesta a Droga , Famotidina/farmacología , Ayuno/fisiología , Ácido Gástrico/metabolismo , Vaciamiento Gástrico/efectos de los fármacos , Antagonistas de los Receptores H2 de la Histamina/farmacología , Humanos , Masculino , Actividad Motora/efectos de los fármacos , Píloro/fisiología , Ratas , Ratas Sprague-DawleyRESUMEN
We investigated the effects of Z-103, ZnSO4, L-carnosine and solcoseryl on wound healing by dermal incision in guinea pigs. The tensile strength, hydroxyproline contents and the value of angiogenesis (carmine contents) at the wounded site of dorsal skin were used as indices of wound healing. Z-103, given daily s.c., increased the tensile strength and hydroxyproline contents on day 4 after operation in a dose-dependent manner; in particular, the effect of 10 mg/kg of Z-103 was nearly equal to that of solcoseryl at 0.5 ml/animal. Moreover, Z-103 10 mg/kg increased the value of angiogenesis on day 3 after the operation. On the other hand, ZnSO4 and L-carnosine, components of Z-103, also similarly increased the tensile strength and hydroxyproline contents. These results suggest that Z-103 possessed an accelerative action on wound healing, and these effects may be due to the activity of its components, ZnSO4 and L-carnosine.
Asunto(s)
Antiulcerosos/farmacología , Carnosina/análogos & derivados , Dipéptidos/farmacología , Compuestos Organometálicos/farmacología , Piel/fisiopatología , Cicatrización de Heridas/efectos de los fármacos , Animales , Modelos Animales de Enfermedad , Cobayas , Hidroxiprolina/metabolismo , Masculino , Neovascularización Patológica , Piel/irrigación sanguínea , Piel/metabolismo , Resistencia a la Tracción/efectos de los fármacos , Compuestos de ZincRESUMEN
We studied the healing promoting action of Z-103 on the chronic gastric ulcer induced by acetic acid (AAU) or Fe-ascorbic acid (FAU) in rats. The area of the gastric ulcers, hydroxyproline (Hyp) and DNA contents in the ulcer region were measured as an index of ulcer healing. The area of gastric ulcers was the largest on day 4 and thereafter gradually decreased, but the ulcers still remained at the 14th day. Hyp contents in the ulcer region decreased until the 7th day in both models, and then this level increased. Significant decrease in DNA contents in the ulcer region was observed on the 7th day only in FAU. In AAU and FAU, administration of Z-103 (3 mg/kg/day x 2, p.o.) resulted in a significant decrease in the area of gastric ulcers on the 14th day and a significant increase in Hyp contents in the ulcer region on the 7th day as compared with the control group. Z-103 increased the DNA contents in the ulcer region on the 4th day in AAU and on the 7th day in FAU. These results suggest that tissue destruction surrounding the ulcer region in AAU and FAU models might occur until the 4th or 7th day after operation, and that the acceleration of ulcer healing by Z-103 on these models may be facilitated by the wound healing action of this drug.
Asunto(s)
Antiulcerosos/farmacología , Carnosina/análogos & derivados , Dipéptidos/farmacología , Compuestos Organometálicos/farmacología , Úlcera Gástrica/tratamiento farmacológico , Zinc/farmacología , Animales , Antiulcerosos/uso terapéutico , ADN/análisis , Dipéptidos/uso terapéutico , Modelos Animales de Enfermedad , Hidroxiprolina/análisis , Masculino , Compuestos Organometálicos/uso terapéutico , Ratas , Ratas Endogámicas , Cicatrización de Heridas/efectos de los fármacos , Zinc/uso terapéutico , Compuestos de ZincRESUMEN
The gastric mucosal adhesiveness of Z-103 in rats with acetic acid ulcer was studied macroscopically, histologically, and biochemically. From macroscopical observations, when Z-103 was orally administered to an acetic acid ulcer model, there was adhesion of Zn to the normal mucosa as well as the ulcerous site under both the fasting condition and after feeding. It was also proven that the strength and duration of adhesiveness were increased dose-dependently under fasting conditions. In addition, histological localization of Zn was noted from the covering epithelial cell layer to the gastric lamina propria mucosae in the normal tissue and in the most superficial ulcerous layer and the granulous layer of the ulcerous site. Measurement of the gastric tissue Zn content after oral administration of 100 mg/kg of Zn showed that the Zn content was significantly increased for 6 hr at the normal site and for 24 hr at the ulcerous site. On the other hand, although ZnSO4 and ZnSO4+carnosine combination macroscopically produced generally the same level of adhesiveness as Z-103, when the gastric tissue Zn content for Z-103 and ZnSO4 were compared, the Zn content of ZnSO4 was lower than that for Z-103 at both the normal and ulcerous site. In summary, Z-103 shows a long-term adhesive and permeable action on the gastric mucosa in acetic acid ulcer rats, and it has a comparable high affinity at the ulcerous site.
Asunto(s)
Antiulcerosos/farmacocinética , Carnosina/análogos & derivados , Dipéptidos/farmacocinética , Mucosa Gástrica/metabolismo , Compuestos Organometálicos/farmacocinética , Úlcera Gástrica/metabolismo , Acetatos , Ácido Acético , Adhesividad , Animales , Enfermedad Crónica , Ayuno/metabolismo , Masculino , Ratas , Ratas Endogámicas , Úlcera Gástrica/inducido químicamente , Zinc/farmacocinética , Compuestos de ZincRESUMEN
Nizatidine (N-[2-[[[2-[(dimethylamino)methyl]- 4-thiazolyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine , CAS 76963-41-2) is a new histamine H2-receptor antagonist which shows suppression of gastric acid secretion and antiulcer activity. In the present experiment, the effects of single s.c. administration of nizatidine, cimetidine and ranitidine on serum gastrin levels were studied in fasted rats. Nizatidine at 100 mg/kg increased serum gastrin level 3 h after administration, which however, returned to basal level 6 h after administration. Cimetidine and ranitidine at respective doses of 250 and 100 mg/kg markedly increased serum gastrin levels 3 and 6 h after administration. In a previous study, the suppressive effect of nizatidine on basal gastric acid secretion was 82.8% at a dose of 100 mg/kg s.c. in rat pylrus-ligated model. On the basis of these findings, changes in basal gastric acid secretion and serum gastrin level after withdrawal of nizatidine, cimetidine and ranitidine administered for 14 consecutive days were studied. One day after withdrawal, nizatidine at 100 mg/kg showed a tendency to increase the basal gastric acid secretion. However, 3 and 7 days after administration, almost no changes were obtained. Cimetidine at 250 mg/kg showed a tendency to increase the basal gastric acid secretion 7 days after withdrawal of the drug. Ranitidine at 100 mg/kg induced no changes in basal gastric acid secretion after withdrawal. No obvious influences of all drugs on serum gastrin level after withdrawals were obtained. These results indicate that consecutive administration of nizatidine may cause only a transient increase of gastric acid secretion but no hypergastrinaemia after its withdrawal.
Asunto(s)
Ácido Gástrico/metabolismo , Gastrinas/sangre , Nizatidina/farmacología , Animales , Cimetidina/efectos adversos , Cimetidina/farmacología , Masculino , Nizatidina/efectos adversos , Píloro/fisiología , Ranitidina/efectos adversos , Ranitidina/farmacología , Ratas , Ratas Endogámicas , Síndrome de Abstinencia a Sustancias/metabolismoRESUMEN
We investigated the anti-ulcer effects of zinc L-carnosine (Z-103) using several acute experimental models of gastric and duodenal lesions in rats. Effects of Z-103 on various gastric functions, e.g., antacid (in vitro), anti-pepsin (in vitro), gastric secretion, mucosal potential difference (PD) and mucus contents were also examined. Z-103 given orally prevented development of gastric lesions induced by water immersion stress, histamine, HCl-aspirin, HCl-ethanol and also duodenal ulcers induced by mepirizole in a dose-dependent manner. In vitro, Z-103 had a greater antacid effect than sodium bicarbonate; and moreover, the potency of its anti-peptic action (IC50 = 8.7 mM) was higher than those of several other drugs (sodium bicarbonate, sucrose sulfate and aceglutamide aluminum). Intragastric treatment of Z-103 (100 mg/kg alone tended to increase PD, and it also significantly inhibited the decrease in PD induced by aspirin. In addition, pretreatment with Z-103 at 10 and 30 mg/kg (p.o.) significantly prevented the decrease in mucus contents in the gastric mucosa and also mucosal lesions by oral administration of ethanol. On the other hand, Z-103 was not so effective on both basal (pylorus-ligation preparation) and histamine-stimulated gastric secretion (Heidenhain pouch preparation). These results suggest that Z-103 is useful for the treatment of gastric and duodenal ulcers in humans.